Hybrid Seminar – CMC and Regulatory Strategies for Antibody Therapeutics (mAbs, BsAbs & TsAbs)

As antibody therapeutics continue to advance the next generation of biologics, developers face increasing challenges in process development, manufacturing, and regulatory compliance. Successfully navigating the journey from development to commercialization requires a well-integrated CMC and regulatory strategy to ensure product quality, scalability, and regulatory readiness.

Join leading industry experts to gain practical insights, proven strategies, and real-world experience in overcoming these challenges and accelerate the path to commercialization.